Security key
79400X107
SALARIUS PHARMACEUTICALS INC - COM NEW (SLRX)
CUSIP: 79400X107
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 6,707,060
- Total 13F value
- $6,842,658
- Share change
- -3,405,922
- SEC-reported price per share
- $1.02
- Number of holders
- 24
- Value change
- -$3,631,755
- Number of buys
- 12
- Number of sells
- 14
Report period
Q3 2021
Institutions
24
Top holders
10
SLRX full security history
Ownership snapshot
Full 13F holder table
Decoy Therapeutics Inc. SEC filings
Decoy Therapeutics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SLRX - SALARIUS PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AIGH Capital Management LLC
Disclosed value leader
AIGH Capital Management LLC
Comparable rows
0/15
Latest evidence
30 Jun 2021
13F
Highest disclosed value: $1,909,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
AIGH Capital Management LLC has the largest disclosed position value at $1.91M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AIGH Capital Management LLC's linked filing trail.
Disclosed position value
Top 5
AIGH Capital Management LLC
$1.91M
VANGUARD GROUP INC
$1.64M
Sio Capital Management, LLC
$1.44M
Maven Securities LTD
$1.37M
Granite Point Capital Management,...
$621K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| AIGH Capital Management LLC |
13F
Company
|
—
denominator unverified
|
$1,909,000
1,800,000 shares
|
— | 30 Jun 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$1,638,000
1,544,724 shares
|
— | 30 Jun 2021 |
| Sio Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$1,436,000
1,354,291 shares
|
— | 30 Jun 2021 |
| Maven Securities LTD |
13F
Company
|
—
denominator unverified
|
$1,369,000
1,316,205 shares
|
— | 30 Jun 2021 |
| Granite Point Capital Management, L.P. |
13F
Company
|
—
denominator unverified
|
$621,000
585,409 shares
|
— | 30 Jun 2021 |
| Kepos Capital LP |
13F
Company
|
—
denominator unverified
|
$581,000
548,054 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
24
Shares
6,707,060
Rows available
24
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
29
Q3 2021 holders
24
Holder diff
-5
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|